Stockreport

Kronos Bio Announces Participation in Medical and Investor Conferences in September

Kronos Bio, Inc.  (KRON) 
PDF SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeut [Read more]